Clinical Practice Guidelines and Recommendations for the Prevention and Treatment of Contrast Induced Acute Kidney Injury

Accredited Article in PFD Format

Sponsored by North American Center for Continuing Medical Education, LLC

Presenters

Roxana Mehran, MD, FACC, Chair & Moderator
Associate Professor of Medicine
Joint Chief Scientific Offices, Clinical Trial Center
Columbia University
Cardiovascular Research Foundation
New York, New York

Samin K. Sharma, MD., FSCAI
Director, Cardiac Catheterization Lab and Intervention
Zena and Michael A. Wiener Professor of Medicine
Co-Director, Cardiovascular Institute
The Mount Sinai Medical Center
New York, New York

Professor Rainer Schräder, MD
Markuskrankenhaus
Med. Klinik III-CCB
Frankfurt, Germany

Carlo Briguori, MD, Phd
Interventional Cardiology
Clinica Mediterranea
Via Orazio, 2, I-80121
Naples, Italy

Antonio Colombo, MD
Director Cardiac Cath Lab and Interventional Cardiology
EMO GVM Centro Cuore Columbus
Milan, Italy

Richard Solomon, MD, FASN
Professor of Medicine,
University of Vermont
Director, Division of Nephrology,
Fletcher Allen Health Care
Burlington, Vermont

Jonathan Reiner, MD
Director, Cardiac Catheterization Lab
Professor of Medicine
The George Washington University Medical Center
Washington, District of Columbia

Rasha Al-Lamee MA MRCP
EMO GVM Centro Cuore Columbus
Milan ,Italy

Intended Learners

This activity is designed for interventional cardiologists, cardiologists, nephrologists, radiologists, nurses and technologists.

Learning Objectives

After completing this activity, participants should be able to:

• Explain new predictors of outcomes and impact on PCI and Cath Lab Procedures in High Risk Patients
• Make recommendations about CI-AKI in CKD patients to support societies like ACC and AHA to develop guidelines
• Discuss areas of clinical need requiring additional research including:
   -use of biomarkers
  -educational programs and awareness
  -guideline development
  -contrast selection
  -protocols
  -registry
  -new technology
  -research

Activity Overview

This accredited monograph is available in pdf format.

Log on to http://www.naccme.com successfully complete the post-test and evaluation form online, and immediately print documentation of credit.  To be eligible for documentation of credit, participants must read all supplement content, complete the 40-question post-test with a score of 75% or better, and complete the evaluation form. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit.

There is no fee associated with this activity.

Release Date: December 1, 2009

Expiration Date: January 31, 2012  

Estimated time to complete:  2 hours

For questions regarding this activity, please call 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

CME Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NACCME designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits ™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.  This continuing nursing education activity was approved for 2 contact hours.  Provider #: 110-3-E-06.

Provider approved by the California Board of Registered Nursing, Provider Number 13255 for 2 contact hours.

AHRA Accreditation

Approved for 2 ARRT Category A CE credits by AHRA.

Independent Clinical Reviewer

Nicolas W. Shammas, MD, FACC, FACP, FCCP, FSCAI
President, Midwest Cardiovascular Research Foundation
Davenport, Iowa

Planning Committee

The planning committee comprises Roxanna Mehran, MD, Carlo Briguori, MD, PhD, Richard Solomon, MD, Samin K. Sharma, MD., FSCAI, Jonathan Reiner, MD, Rainer Schräder, MD, Antonio Colombo, MD, Rasha Al-Lamee MA MRCP and Nicolas Shammas, MD;  Alex Slonim, Lindsay Mazzagatti and Patricia Levy, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity.  All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest.  If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
                
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:
Dr. Mehran has disclosed that she has received grant/research support from The Medicines Company and Sanofi/Aventis. She is a consultant for The Medicines Company, Abbott, Cordis, Boston Scientific, Bracco, Medtronic Vascular, and Daiichi Sankyo Lilly.  She is a scientific advisor to Guerbert and Regado.

Dr. Briguori has disclosed that he has no relevant financial relationships with any commercial interest

Dr. Colombo has reported no relevant financial relationships with any commercial interest.

Dr. Reiner has disclosed that he is a member of the speakers’ bureau for Bracco Diagnostics, Inc. and Eli Lilly. He has received grant/research support from Merck. He is a consultant to Cordis and Abbott.

Dr. Schräder has disclosed that he has no relevant financial relationships with any commercial interest.

Dr. Sharma has disclosed that he is a member of the promotional speakers’ bureau for Abbott, Boston Scientific, Cordis, The Medicines Company and Lilly.

Dr. Solomon has disclosed that he is a consultant and scientific advisor to Bracco Diagnostics, Covidien and PLC.

Rasha Al-Lamee MA MRCP has disclosed that he has no relevant financial relationships with any commercial interest.

Dr. Shammas has disclosed that he has no relevant financial relationships with any commercial interest

Alex Slonim, Lindsay Mazzagatti and Patricia Levy have reported no relevant financial relationships with any commercial interest.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed the following off-label/unapproved use(s) of drugs and/or devices will be discussed: The use of drug eluting stents for the treatment of complex lesions.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2009 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.

Grant Support

Supported by an educational grant from Bracco Diagnostics, Inc.